NFE2L2 and Alzheimer disease: In a study involving an AD mouse model, quercetin treatment significantly reduced skin lesions and inflammation by modulating the high mobility group box 1/receptor advanced glycation end products/NFκB signaling pathway and enhancing the expression of the Nrf2 protein [58].